Events | Verve Therapeutics
The Investor Relations website contains information about Verve Therapeutics’s business for stockholders, potential investors, and financial analysts.
Related Articles
ASE Soulmates Program
Refer two NEW members to join ASE from September 2024 through August 31, 2025 and receive 25% off on your 2026 membership. Refer three or…
Accommodations
ASE has secured a block of discounted rooms at the Westin Kierland Resort & Spa. The room block is designated for conference attendees only. Reservations…
State of the Art in Left Atrial Appendage Occlusion:
AbstractLeft atrial appendage occlusion (LAAO) has become an important therapeutic target for stroke prevention in patients with nonvalvular atrial fibrillation. Over the past 2 decades,…
Stroke Alert January 2025 | AHA Podcasts
Negar Asdaghi, MD, MSc Eric D. Goldstein, MD Nastajjia Krementz, MD Dr. Negar Asdaghi: Let’s start with some questions. 1) Does endovascular treatment of cerebral…
GHA-SCAI SHOCK MENA | SCAI
The Gulf Heart Association (GHA) and SCAI are pleased to announce the Second Annual GHA-SCAI SHOCK MENA meeting scheduled for January 24-25, 2025 in Riyadh,…
Women in Cardiothoracic Leadership: Work-Life Balance
At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions…
Decision Aids – ICDs | CardioSmart – American College of Cardiology
Use these resources to help guide conversations with patients for whom an implantable cardioverter-defibrillator (ICD) is indicated and being recommended.
Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit
The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.
Single Cell Transcriptomic Profiling of MYBPC3‐Associated Hypertrophic Cardiomyopathy Across Species Reveals Conservation of Biological Process But Not Gene Expression | Journal of the American Heart Association
BackgroundHypertrophic cardiomyopathy (HCM) is a common heritable heart disease where the most frequently associated mutations occur in the myosin‐binding protein C (MYBPC3) sarcomere‐associated ge…
F-CK ALS Gala – Lala Fighting ALS | Mobile bidding + auction software
Join us for the first annual F*CK ALS Gala, a glamourous night of giving and grooving dedicated to supporting young women diagnosed with ALS (Amyotrophic…
